Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BI-836880 by Boehringer Ingelheim International for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
BI-836880 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Wet (Neovascular / Exudative) Macular...